ATARA Biotherapeutics (ATRA) Misses Q4 EPS by 27c
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Join SI Premium – FREE
ATARA Biotherapeutics (NASDAQ: ATRA) reported Q4 EPS of ($0.96), $0.27 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
